A multicenter, prospective, non-interventional drug intensive monitoring study of olaparib in a large real-world Chinese patient cohort with ovarian cancer (DIM-OC)
一项针对中国卵巢癌真实世界患者队列的大型真实世界奥拉帕尼药物强化监测多中心、前瞻性、非干预性研究（DIM-OC）
期刊:Journal of Ovarian Research
影响因子:4.2
doi:10.1186/s13048-025-01924-8
Wang, Li; Xie, Lingling; Li, Qingshui; Shen, Yang; Wang, Huaying; Sun, Li; Yang, Hongying; Cao, Dongyan; Li, Haiying; Lin, Bei; Chen, Qionghua; Guo, Ruixia; Lou, Ge; Liu, Ziling; Shen, Yuanming; Feng, Weiwei; Zhang, Ping; Zhou, Jianwei; Wang, Xipeng; Wang, Yue; Shen, Zhen; Xue, Fengxia; Ma, Liguo; Tu, Chunhua; Yang, Yingjie; Cheng, Wenjun; Zhang, Yi; Kang, Shan; Li, Congzhu; Wen, Hongwu; Wu, Xin; Luo, Xiping; Yin, Rutie; Lin, Zhongqiu
